Screener
Arcutis Biotherapeutics, Inc. ARQT Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s gross margin?
- Arcutis Biotherapeutics, Inc. (ARQT) reported gross margin of 91.1% in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s gross margin changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s gross margin increased by 2.3% year-over-year, from 89.1% to 91.1%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s gross margin?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s gross margin has grown at a 4.3% compound annual growth rate (CAGR), from 79.5% to 90.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Arcutis Biotherapeutics, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude